Agilent Technologies, Inc. (NYSE:A) Shares Sold by Saturna Capital Corp

Saturna Capital Corp lowered its position in Agilent Technologies, Inc. (NYSE:A) by 0.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 905,686 shares of the medical research company’s stock after selling 4,780 shares during the quarter. Agilent Technologies comprises approximately 1.8% of Saturna Capital Corp’s investment portfolio, making the stock its 20th biggest holding. Saturna Capital Corp owned 0.32% of Agilent Technologies worth $134,476,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Crewe Advisors LLC lifted its holdings in Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares during the period. Livelsberger Financial Advisory acquired a new stake in shares of Agilent Technologies in the 3rd quarter worth approximately $28,000. Ridgewood Investments LLC bought a new position in shares of Agilent Technologies in the second quarter valued at approximately $29,000. Ashton Thomas Securities LLC acquired a new position in shares of Agilent Technologies during the third quarter valued at approximately $31,000. Finally, Fortitude Family Office LLC raised its holdings in Agilent Technologies by 68.3% during the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock worth $35,000 after purchasing an additional 95 shares in the last quarter.

Analysts Set New Price Targets

A has been the subject of several research reports. UBS Group raised their price objective on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. Citigroup raised their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. TD Cowen upped their price target on Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Barclays increased their price objective on Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a research report on Tuesday, October 15th. Finally, Evercore ISI boosted their target price on Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $144.36.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the sale, the chief executive officer now owns 24,118 shares of the company’s stock, valued at $3,497,110. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the transaction, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 11,995 shares of company stock valued at $1,739,510.

Agilent Technologies Stock Down 0.5 %

Agilent Technologies stock opened at $132.96 on Wednesday. The firm has a market capitalization of $38.20 billion, a price-to-earnings ratio of 27.73, a PEG ratio of 5.89 and a beta of 1.07. The company’s 50 day simple moving average is $139.17 and its 200 day simple moving average is $138.16. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. Agilent Technologies, Inc. has a fifty-two week low of $109.46 and a fifty-two week high of $155.35.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the previous year, the firm earned $1.43 earnings per share. The company’s revenue was down 5.6% on a year-over-year basis. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st were issued a dividend of $0.236 per share. The ex-dividend date was Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.71%. Agilent Technologies’s payout ratio is presently 19.50%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.